FIFTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2017 • Arqule Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionThis Fifth Amendment to Employment Agreement (“Fifth Amendment”), effective as of April 4, 2017 (the “Effective Date”) is entered into by and between ArQule, Inc., a Delaware corporation (the “Company”) with its principal offices at One Wall Street, Burlington, Massachusetts 01803, and Peter Lawrence (“Executive”). The purpose of this Fifth Amendment is to amend the employment agreement dated as of April 13, 2006 between the Company and Executive, as previously amended (the “Employment Agreement”). Capitalized terms used but not defined in this Fifth Amendment shall have the meanings ascribed to them in the Employment Agreement.
FOURTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2017 • Arqule Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionThis Fourth Amendment to Employment Agreement (“Fourth Amendment”), effective as of April 4, 2017 (the “Effective Date”) is entered into by and between ArQule, Inc., a Delaware corporation (the “Company”) with its principal offices at One Wall Street, Burlington, Massachusetts 01803, and Brian Schwartz (“Executive”). The purpose of this Fourth Amendment is to amend the employment agreement dated as of June 17, 2008 between the Company and Executive, as previously amended (the “Employment Agreement”). Capitalized terms used but not defined in this Fourth Amendment shall have the meanings ascribed to them in the Employment Agreement.
FOURTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 10th, 2017 • Arqule Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionThis Fourth Amendment to Employment Agreement (“Fourth Amendment”), effective as of April 4, 2017 (the “Effective Date”) is entered into by and between ArQule, Inc., a Delaware corporation (the “Company”) with its principal offices at One Wall Street, Burlington, Massachusetts 01803, and Paolo Pucci (“Executive”). The purpose of this Fourth Amendment is to amend the employment agreement dated as of April 15, 2008 between the Company and Executive, as previously amended (the “Employment Agreement”). Capitalized terms used but not defined in this Fourth Amendment shall have the meanings ascribed to them in the Employment Agreement.
ARQULE, INC. PERFORMANCE STOCK OPTION AGREEMENTPerformance Stock Option Agreement • April 10th, 2017 • Arqule Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionTHIS PERFORMANCE STOCK OPTION AGREEMENT (the “Option Agreement”) is dated as of April 5, 2017 (the “Grant Date”) by and between ArQule, Inc., a Delaware Company (the “Company”), and ____________________ (the “Participant”). Capitalized terms used herein and not otherwise defined shall have the meaning assigned to such terms in the ArQule, Inc. 2014 Equity Incentives Plan (the “Plan”).